Riskpilot← Back to searchSign inGet full accessE-APOTEKET AS
ASActiveOrg 925566047Naustdalsvegen 1B, 6800 FørdeWholesale of pharmaceutical and medical goods · NACE 4646Est. 20209 employees
Revenue 2024
NOK 17,5M
+60% vs 2023
EBITDA margin
2.2%
+156% vs 2023
Equity ratio
-65.9%
Financial strength
Net profit 2024
NOK -4K
+100% vs 2023
| Revenue | NOK 17,5M | +60% |
| EBITDA | NOK 385K | +156% |
| Net profit | NOK -4K | +100% |
| Total assets | NOK 3,6M | +16% |
| Equity | NOK -2,4M | +0% |
| Employees | 9 | — |
Legal name
E-APOTEKET AS
Org number
925566047
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2. september 2020
Share capital
NOK 100 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Selskapets formål er salg av apotekvarer og andre tjenester som naturlig hører sammen med dette. Selskapets virksomhet skal også delta i andre selskaper gjennom investeringer i aksjer og selskapsandeler, samt alt hva hermed står i forbindelse. Selskapet skal også drive med utleie av arbeidskraft.
Address
Naustdalsvegen 1B, 6800 Førde
Phone
+4757743300
Email
post@e-apoteket.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1 515 | 10 931 | 17 505 |
| Staff expenses | −0 | −0 | −947 | −2 867 | −2 923 |
| EBITDA | −50 | −249 | −1 315 | −682 | 385 |
| Depreciation & amort. | −0 | −0 | −33 | −138 | −139 |
| EBIT | −50 | −249 | −1 348 | −820 | 246 |
| Net financials | −23 | −54 | −82 | −247 | −250 |
| Profit before tax | −73 | −303 | −1 430 | −1 067 | −4 |
| Tax | −17 | −67 | −0 | −0 | −0 |
| Net profit | −56 | −236 | −1 430 | −1 067 | −4 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 279 | 1 159 | 2 913 | 3 149 | 3 644 |
| Equity | 100 | 100 | −1 330 | −2 397 | −2 401 |
| Long-term debt | 1 170 | 1 055 | 2 282 | 3 462 | 3 342 |
| Short-term debt | 9 | 3 | 1 961 | 2 083 | 2 702 |
| Total debt | 1 179 | 1 059 | 4 243 | 5 546 | 6 045 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20202024
Equity ratio
-65.9%
This company
38.2%
Market median
-273% vs market
20202024
Return on equity
-385300.0%
This company
18.4%
Market median
-2094122% vs market
20202024
Net profit margin
-0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
4.80×
This company
1.12×
Market median
+329% vs market
20202024
Debt / equity
2.52×
This company
0.62×
Market median
-306% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-08-12 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JB Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
HK Deputy Member | Deputy Member | 2020 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Viking Capital Holding As | Company | 68.0% | 68.0% | 2022 |
| Individual | 16.0% | 16.0% | 2022 | |
| Individual | 16.0% | 16.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of E-APOTEKET AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jostein Brudevoll | Chief Executive Officer | 0 companies |
| Hans Kjølen | Deputy Member | 0 companies |